Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma in Situ × dodecyl maltoside × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma in Situ 1

Interventions

valrubicin 1 dodecyl maltoside 1 Standard of Care 1 Physical Examination 1 Methods 1 Mastectomy, Subcutaneous 1 Erlotinib Hydrochloride 1 Educational Status 1 Early Intervention, Educational 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04452591 2026-03-16

BOND-003

CG Oncology, Inc.

Phase 3 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡